Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Backs Proposed SPF Cap For Sunscreens, In Break From Rivals

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble files comments in support of FDA’s proposed 50+ SPF cap for OTC sunscreens, maintaining that high-SPF products do not provide a significant incremental protective benefit. P&G also cites harmonization with international regulatory frameworks in comments to FDA.

You may also be interested in...



Senators Push FDA For SPF Cap, Spray Sunscreen Review

Nine Democrats led by Senator Jack Reed ask FDA to resolve sunscreen issues that remain in regulatory limbo. FDA needs to clarify “misconceptions about misleadingly high SPF labels beyond 50, where the increase in UV protection is relatively small,” the senators suggest.

CHPA: Sunscreen Efficacy Ceiling Is More Harmful Than SPF Claim Limit

FDA should not impose an efficacy ceiling on sunscreen formulations even if it caps sun protection factor label claims at 50 or 50+, industry stakeholders argue.

FDA Considers Capping SPF Values At 50+ Despite Efficacy Data

FDA might cap sun protection values at 50 or 50+ so as not to mislead consumers about the clinical benefit of sunscreens with higher SPF values, according to a proposed rule.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS105417

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel